Studies have shown that immune responses triggered by vaccine components may generate antibodies against MBP, leading to autoimmune-mediated demyelinating disorders such as postvaccinal encephalomyelitis in a subset of recipients [56]. The gene discussed is MBP; the disease is demyelinating disease.